Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Interest Coverage Ratio (2021 - 2025)

Historic Interest Coverage Ratio for BioNexus Gene Lab (BGLC) over the last 5 years, with Q3 2025 value amounting to 108.38.

  • BioNexus Gene Lab's Interest Coverage Ratio rose 4982.23% to 108.38 in Q3 2025 from the same period last year, while for Sep 2025 it was 106.35, marking a year-over-year decrease of 13069.75%. This contributed to the annual value of 74.42 for FY2024, which is 6003.19% up from last year.
  • Per BioNexus Gene Lab's latest filing, its Interest Coverage Ratio stood at 108.38 for Q3 2025, which was up 4982.23% from 125.29 recorded in Q2 2025.
  • In the past 5 years, BioNexus Gene Lab's Interest Coverage Ratio registered a high of 89.48 during Q2 2023, and its lowest value of 593.69 during Q3 2023.
  • Its 5-year average for Interest Coverage Ratio is 66.85, with a median of 33.7 in 2024.
  • Over the last 5 years, BioNexus Gene Lab's Interest Coverage Ratio had its largest YoY gain of 25040.5% in 2023, and its largest YoY loss of 198625.16% in 2023.
  • Quarter analysis of 5 years shows BioNexus Gene Lab's Interest Coverage Ratio stood at 50.44 in 2021, then skyrocketed by 151.08% to 25.76 in 2022, then soared by 139.17% to 61.62 in 2023, then crashed by 216.22% to 71.61 in 2024, then crashed by 51.34% to 108.38 in 2025.
  • Its Interest Coverage Ratio was 108.38 in Q3 2025, compared to 125.29 in Q2 2025 and 125.98 in Q1 2025.